Stromal mesenchyme cell genes of the human prostate and bladder

被引:35
作者
Young A.G. [1 ,2 ,3 ]
Goodlett D.R. [1 ,2 ,3 ]
Pascal L.E. [1 ,3 ]
Worthington K.D. [1 ]
Vessella R.L. [1 ,4 ]
True L.D. [5 ]
Liu A.Y. [1 ,3 ]
机构
[1] Department of Urology, University of Washington, Seattle, WA
[2] Department of Medicinal Chemistry, University of Washington, Seattle, WA
[3] Institute for Systems Biology, Seattle, WA
[4] Puget Sound VA Health Care System, Seattle, WA
[5] Department of Pathology, University of Washington, Seattle, WA
关键词
Stromal Cell; Reverse Transcriptase Polymerase Chain Reaction; Stromal Mesenchyme Cell; Bladder Tissue; Cluster Designation;
D O I
10.1186/1471-2490-5-17
中图分类号
学科分类号
摘要
Background: Stromal mesenchyme cells play an important role in epithelial differentiation and likely in cancer as well. Induction of epithelial differentiation is organ-specific, and the genes responsible could be identified through a comparative genomic analysis of the stromal cells from two different organs. These genes might be aberrantly expressed in cancer since cancer could be viewed as due to a defect in stromal signaling. We propose to identify the prostate stromal genes by analysis of differentially expressed genes between prostate and bladder stromal cells, and to examine their expression in prostate cancer. Methods: Immunohistochemistry using antibodies to cluster designation (CD) cell surface antigens was first used to characterize the stromas of the prostate and bladder. Stromal cells were prepared from either prostate or bladder tissue for cell culture. RNA was isolated from the cultured cells and analyzed by DNA microarrays. Expression of candidate genes in normal prostate and prostate cancer was examined by RTPCR. Results: The bladder stroma was phenotypically different from that of the prostate. Most notable was the presence of a layer of CD13+ cells adjacent to the urothelium. This structural feature was also seen in the mouse bladder. The prostate stroma was uniformly CD13-. A number of differentially expressed genes between prostate and bladder stromal cells were identified. One prostate gene, proenkephalin (PENK), was of interest because it encodes a hormone. Secreted proteins such as hormones and bioactive peptides are known to mediate cell-cell signaling. Prostate stromal expression of PENK was verified by an antibody raised against a PENK peptide, by RT-PCR analysis of laser-capture microdissected stromal cells, and by database analysis. Gene expression analysis showed that PENK expression was down-regulated in prostate cancer. Conclusion: Our findings show that the histologically similar stromas of the prostate and bladder are phenotypically different, and express organ-specific genes. The importance of these genes in epithelial development is suggested by their abnormal expression in cancer. Among the candidates is the hormone PENK and the down-regulation of PENK expression in cancer suggests a possible association with cancer development. © 2005 Ah Goo et al; licensee BioMed Central Ltd.
引用
收藏
页数:11
相关论文
共 20 条
[1]  
Cunha G.R., Alarid E.T., Turner T., Donjacour A.A., Boutin E.L., Foster B.A., Normal and abnormal development of the male urogenital tract. Role of androgen, mesenchymal-epithelial interactions, and growth factors, J Androl, 13, pp. 465-475, (1992)
[2]  
Aboseif S., El-Sakka A., Young P., Cunha G.R., Mesenchymal reprogramming of adult human epithelial differentiation, Differentiation, 65, pp. 113-118, (1999)
[3]  
Bissell M.J., Ram T.G., Regulation of functional cytodifferentiation and histogenesis in mammary epithelial cells: Role of the extracellular matrix, Environ Health Persp, 80, pp. 61-70, (1989)
[4]  
Lee C., Role of androgen in prostate growth and regression: Stromal-epithelial interaction, Prostate, pp. 52-56, (1996)
[5]  
Kedinger M., Lefebvre O., Duluc I., Freund J.N., Simon-Assmann P., Cellular and molecular partners involved in gut morphogenesis and differentiation, Phil Trans R Soc Lond B Biol Sci, 353, pp. 847-856, (1998)
[6]  
Saxen L., What is needed for kidney differentiation and how do we find it, Int J Dev Biol, 43, pp. 377-380, (1999)
[7]  
Roudier M.P., True L.D., Higano C.S., Vesselle H., Ellis W., Lange P., Vessella R.L., Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone, Hum Pathol, 34, pp. 646-653, (2003)
[8]  
Liu A.Y., LaTray L., Van Den Engh G., Changes in cell surface molecules associated with in vitro culture of prostatic stromal cells, Prostate, 45, pp. 303-312, (2000)
[9]  
Liu A.Y., True L.D., Characterization of prostate cell types by CD cell surface molecules, Am J Pathol, 160, pp. 37-43, (2002)
[10]  
Liu A.Y., Roudier M.P., True L.D., Heterogeneity in primary and metastatic prostate cancer as defined by cell surface CD profile, Am J Pathol, 165, pp. 1543-1556, (2004)